Publications by authors named "John Pippen"

Claim this Profile
P
Presentation, diagnosis, and management of the Li-Fraumeni syndrome.
John Ogden, John Pippen

Proc (Bayl Univ Med Cent)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A medical student perspective on solutions for burnout.
Graham R Aufricht, Jonathan H Brewer, Ashlee L Culver, Rebecca A Fitzpatrick, Caleb P Gottlich, John E Pippen

Proc (Bayl Univ Med Cent)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinoma en cuirasse.
Ashlee L Culver, David M Metter, John E Pippen

Proc (Bayl Univ Med Cent)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-radiologic features and management of hematological tumors in the breast: a case series.
Joseph T Hoang, Robert Yang, Zeeshan A Shah, Joseph J Spigel, John E Pippen

Breast Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giant malignant phyllodes tumor with metastasis to the brain.
Alden P Gregston, David M Metter, Cynthia R C Osborne, John Pippen

Proc (Bayl Univ Med Cent)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
Frankie Ann Holmes, Beth A Hellerstedt, John E Pippen, Svetislava J Vukelja, Rufus P Collea

Cancer Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.
Joanne L Blum, Nicholas Robert, Jay Andersen, Anne Favret, Patrick Ward, John Pippen

J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cancers in one: breast carcinoma with underlying melanoma.
Nicholas A Douville, Elizabeth A Sakach, Elizabeth A Wiewiorowski, William Herlihy, John E Pippen

Proc (Bayl Univ Med Cent)· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Joyce O'Shaughnessy, Hartmut Koeppen, Yuanyuan Xiao, Mark R Lackner, Devchand Paul, John Pippen

Clin Cancer Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic alterations in DNA repair and chromatin remodeling genes in estrogen receptor-positive metastatic breast cancer patients with exceptional responses to capecitabine.
Maren K Levin, Kai Wang, Roman Yelensky, Ying Cao, Corinne Ramos, John Pippen

Cancer Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfaction with work-life balance and the career and retirement plans of US oncologists.
Tait D Shanafelt, Marilyn Raymond, Michael Kosty, Daniel Satele, Leora Horn, John Pippen

J Clin Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burnout and career satisfaction among US oncologists.
Tait D Shanafelt, William J Gradishar, Michael Kosty, Daniel Satele, Helen Chew, John Pippen

J Clin Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.
Frankie Ann Holmes, Virginia Espina, Lance A Liotta, Yasir M Nagarwala, Michael Danso, John Pippen

BMC Res Notes· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Our experience as a Health Volunteers Overseas-sponsored team in Huê´, Vietnam.
James I Ewing, Claude A Denham, Cynthia R Osborne, Nathan B Green, Josephine Divers, John E Pippen

Proc (Bayl Univ Med Cent)· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.
Libero Santarpia, Yuan Qi, Katherine Stemke-Hale, Bailiang Wang, Elliana J Young, John Pippen

Breast Cancer Res Treat· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer.
John Pippen, Devchand Paul, Svetislava Vukelja, Alicia Clawson, Jose Iglesias

Breast Cancer Res Treat· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update.
Reva Schneider, Ayman Barakat, John Pippen, Cynthia Osborne

Breast Cancer (Dove Med Press)· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sensitivity and specificity of sentinel lymph node biopsy for breast cancer at Baylor University Medical Center at Dallas: a retrospective review of 488 cases.
S Michelle Shiller, Robert Weir, John Pippen, Metin Punar, Daniel Savino

Proc (Bayl Univ Med Cent)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory breast cancer: the experience of Baylor University Medical Center at Dallas.
Justin M Goldfarb, John E Pippen

Proc (Bayl Univ Med Cent)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.
Takayuki Iwamoto, Giampaolo Bianchini, Daniel Booser, Yuan Qi, Charles Coutant, John Pippen

J Natl Cancer Inst· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iniparib plus chemotherapy in metastatic triple-negative breast cancer.
Joyce O'Shaughnessy, Cynthia Osborne, John E Pippen, Mark Yoffe, Debra Patt

N Engl J Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials.
Stuart D Russell, Kimberly L Blackwell, Julia Lawrence, John E Pippen, Matthew T Roe

J Clin Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer.
David Loesch, F Anthony Greco, Neil N Senzer, Howard A Burris, John D Hainsworth, John Pippen

J Clin Oncol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy.
John Pippen, Anthony D Elias, Marcus Neubauer, Christopher Stokoe, LaTrice G Vaughn

Clin Breast Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
Stephen Johnston, John Pippen, Xavier Pivot, Mikhail Lichinitser, Saeed Sadeghi

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis